Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodimel is a topical antioxidant product line developed by the Mexican pharmaceutical company Farmapiel. The formulation's primary active ingredient is Superoxide Dismutase (SOD), an antioxidant enzyme extracted from French Cantaloupe melon (Cucumis melo). Sodimel is designed to neutralize free radicals and combat oxidative stress, which are major contributors to photoaging and skin damage caused by environmental factors like pollution and UV radiation. The topical serum (Sodimel SP or Suero Facial) also incorporates a blend of ceramides, an amino acid complex (acetyl tyrosine and proline), and algae extract-pullulan to support the skin barrier and protect collagen and elastin structures. It is marketed for various skin types to prevent premature aging and maintain skin integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sodimel.